Menu ×

HEALTHCARE & PHARMACEUTICAL

Asia Digital Advertising in Pharma Market Segmentation by Ad Format (Social Media Ads, Native Ads, Search Engine Ads, Display Ads, Video Advertising, Mobile Advertising, Banner Ads, and Other Ads); by Product Type (Patent, and Generic Medicine); by Category (Prescription, and OTC Drugs); and by Platform (Mobile, Desktop, and Other) – Demand Analysis & Opportunity Outlook 2015-2030

  • Text Size:

Extensive insights into the Growth of Asia Digital Advertising in Pharma Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

IN THE NEWS

  • July 6, 2021: BBDO announced that it has been selected as a partner by Creative X, Facebook’s global internal integrated creative agency, for the flagship Facebook app.

Asia Digital Advertising in Pharma Market Highlights Over 2015 - 2030

The Asia digital advertising in pharma market is estimated to garner a revenue of USD 22264.3 Million by the end of 2030 by growing at a CAGR of 13.8% over the forecast period, i.e., 2021 – 2030. Moreover, in the year 2015, the market in the region registered a revenue of USD 3628.0 Million. The growth of the market can be attributed to growing adoption of smartphone in the region, followed by the increasing internet penetration. Besides this, the growing development in the pharmaceutical industry in the region, and the surge in concern for the rising incidences of chronic diseases in the region, are some of the major factors anticipated to drive the market growth. According to the statistics by the International Telecommunication Union (ITU), the number of individuals using the internet in Asia & Pacific grew from 355 Million in the year 2005 to 1901 Million in the year 2019.

Asia digital advertising in pharma market Graph

Moreover, the pharmaceutical advertising industry is rapidly becoming automated which has significantly benefitted businesses. This mode of advertisement is cost-effective and provides greater scale and enhanced efficiency. Additionally, the increasing investment by pharmaceutical industries in the region, along with the rising adoption of advanced technologies, such as artificial intelligence, deep learning, big data, and machine learning among others, are some of the other factors anticipated to drive the market growth in the coming years.CLICK TO DOWNLOAD SAMPLE REPORT

Asia Digital Advertising in Pharma Market Regional Synopsis

On the basis of country, the Asia digital advertising in pharma market is segmented into Singapore, Indonesia, Thailand, Malaysia, Vietnam, Philippines, Hong Kong, Taiwan, Japan, South Korea, Rest of Southeast Asia, and the Rest of Asia. Out of these, the market in Japan is anticipated to hold the second-largest revenue of USD 4942.7 Million by the end of 2030, up from a revenue of USD 878.0 Million in the year 2015. The market in the country is further expected to grow with a CAGR of 13.3% during the forecast period. One of the major factors anticipated to drive the growth of the market in the country is the growing pharmaceutical industry, and the increasing transition of companies towards digital mode of business. According to the statistics by the International Trade Administration (ITA), the total pharmaceutical market size in Japan grew from USD 95856 Thousands in the year 2016 to USD 105545 Thousands in the year 2019. Besides this, the growing penetration of the internet and the increasing adoption of digital platforms by the end-users in the nation are some of the additional factors anticipated to drive the market growth during the forecast period.

Growth Drivers and Challenges Impacting the Growth of the Asia Digital Advertising in Pharma Market

Growth Drivers

  • Increasing Internet Penetration and Surge in Use of Mobile Devices
  • Growing Development in the Pharma Industry

Challenges

  • Increasing Competition in the Digital Advertising Market
  • Evolving Privacy Regulations and Presence of Ad Blockers

Asia Digital Advertising in Pharma Market Segmentation Synopsis

The Asia digital advertising in pharma market is segmented by ad format into social media ads, native ads, search engine ads, display ads, video advertising, mobile advertising, banner ads, and other ads. Out of these, the social media ads segment is anticipated to generate the largest revenue of USD 5023.9 Million by the end of 2030, up from a revenue of USD 746.3 Million in the year 2015. By product type, the market is segmented into patent medicine, and generic medicine. Out of these, the patent medicine segment is expected to grow with the highest CAGR of 14.0% during the forecast period. By category, the market is segmented into prescription drugs, and OTC drugs. Out of these, the prescription drugs segment is anticipated to hold the highest market share throughout the forecast period. The market is further segmented by platform into mobile, desktop, and other platforms. Out of these, the mobile segment is anticipated to generate the largest revenue of USD 16599.8 Million by the end of 2030, up from a revenue of USD 2599.9 Million in the year 2015. The segment is further anticipated to grow with the highest CAGR of 14.1% during the forecast period and also attain a revenue of USD 5078.5 Million by the end of 2021.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the Asia digital advertising in pharma market that are included in our report are BBDO, AMICULUM Limited, WebHopers Infotech PVT. LTD., The Ogilvy Group, WebFX, Amura Marketing Technologies, Medibrandox, and others.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
  • The report includes detailed company profiles of the major players dominating the market.
  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

FREQUENTLY ASKED QUESTIONS

Asia Digital Advertising in Pharma Market TOC

  1. Market Definition and Research Methodology
    1. Market Definition and Segmentation
    2. Assumptions and Acronyms
    3. Research Objective
    4. Research Methodology
  2. Analyst Review
  3. Executive Summary
  4. Market Dynamics
    1. Drivers
    2. Challenges
    3. Trends
    4. Opportunities
  5. Industry Analysis
    1. Regulatory and Standard Landscape
    2. Industry risk analysis
    3. Consumer Behavior Analysis
  6. Impact of COVID-19 on the Asia Digital Advertising in Pharma Market
  7. Spending Analysis on Pharma Medical Sales Representative
  8. Spending Analysis on Pharma Product Advertising
  9. Spending Analysis on Product Sales Incentives and Programs
  10. Analysis on Pharma Companies
  11. Competitive Positioning
  12. Comparative Feature Analysis
  13. Competitive Landscape
  14. Asia Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
        1. Social Media Ads, 2015-2030 (in USD Million)
        2. Native Ads, 2015-2030 (in USD Million)
        3. Search Engine Ads, 2015-2030 (in USD Million)
        4. Display Ads, 2015-2030 (in USD Million)
        5. Video Advertising, 2015-2030 (in USD Million)
        6. Mobile Advertising, 2015-2030 (in USD Million)
        7. Banner Ads, 2015-2030 (in USD Million)
        8. Other Ads, 2015-2030 (in USD Million)
      2. Product Type
        1. Patent Medicine, 2015-2030 (in USD Million)
        2. Generic Medicine, 2015-2030 (in USD Million)
      3. Category
        1. Prescription Drugs, 2015-2030 (in USD Million)
        2. OTC Drugs, 2015-2030 (in USD Million)
      4. Platform
        1. Mobile, 2015-2030 (in USD Million)
        2. Desktop, 2015-2030 (in USD Million)
        3. Other Platforms, 2015-2030 (in USD Million)
      5. Country
        1. Singapore
        2. Indonesia
        3. Thailand
        4. Malaysia
        5. Vietnam
        6. Philippines
        7. Hong Kong
        8. Taiwan
        9. Japan
        10. South Korea
        11. Rest of Southeast Asia
        12. Rest of Asia
  15. Singapore Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
        1. Social Media Ads, 2015-2030 (in USD Million)
        2. Native Ads, 2015-2030 (in USD Million)
        3. Search Engine Ads, 2015-2030 (in USD Million)
        4. Display Ads, 2015-2030 (in USD Million)
        5. Video Advertising, 2015-2030 (in USD Million)
        6. Mobile Advertising, 2015-2030 (in USD Million)
        7. Banner Ads, 2015-2030 (in USD Million)
        8. Other Ads, 2015-2030 (in USD Million)
      2. Product Type
        1. Patent Medicine, 2015-2030 (in USD Million)
        2. Generic Medicine, 2015-2030 (in USD Million)
      3. Category
        1. Prescription Drugs, 2015-2030 (in USD Million)
        2. OTC Drugs, 2015-2030 (in USD Million)
      4. Platform
        1. Mobile, 2015-2030 (in USD Million)
        2. Desktop, 2015-2030 (in USD Million)
        3. Other Platforms, 2015-2030 (in USD Million)
  16. Indonesia Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform
  17. Thailand Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform
  18. Malaysia Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform
  19. Vietnam Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform
  20. Philippines Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform
  21. Hong Kong Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform
  22. Taiwan Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform
  23. Japan Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform
  24. South Korea Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform
  25. Rest of South East Asia Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform
  26. Rest of Asia Digital Advertising in Pharma Market
    1. Market Overview – Market size (2015-2030)
    2. Market Segmentation by:
      1. Ad Format
      2. Product Type
      3. Category
      4. Platform

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved